By Dawn Kopecki, Jarrett Renshaw, Sabrina Valle and Ernest Scheyder NEW YORK, October 2 (Reuters) -Eli Lilly was asked to ...

By Dawn Kopecki, Jarrett Renshaw, Ernest Scheyder and Sabrina Valle NEW YORK, October 2 (Reuters) -Eli Lilly was asked to ...

New data centers and service centers designed to enhance infrastructure coverage and stay ahead of global growing demand for ...

AstraZeneca saw its share prices jump to a new all-time high on Wednesday, as investors cheered reports that President Donald ...

Ten stocks finished the trading session with hefty gains, mirroring a wider market optimism, following President Donald Trump ...

U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla, on the day he announces a deal with Pfizer to sell ...

European and U.S. healthcare stocks surged on Wednesday, propelled by a deal between Pfizer and President Donald Trump to ...

Europe saw key developments Wednesday as Russia prepared asset sales, AstraZeneca shares surged, markets rallied, and German ...

The abrupt termination last month of nearly half a billion dollars in US government contracts for mRNA vaccine research ...

AstraZeneca Up Over 9%, on Pace for Largest Percent Increase Since April 2014 — Data Talk AstraZeneca PLC Sponsored ADR (AZN) is currently at $83.88, up $7.16 or 9.33% --Would be highest close since ...

The Department of Defense funds biomedical research to ensure military and pandemic preparedness. This includes mRNA vaccine ...

AstraZeneca shares rallied on Wednesday after the U.K. giant and its Japanese partner said the Food and Drug Administration ...